Endothelin-1- and endothelin-receptors in lung biopsies of patients with pulmonary hypertension due to congenital heart disease

Clinical Chemistry and Laboratory Medicine

Volumn 37, Issue 4, 1999, Pages 423-428

  Lutz, Jens ^a,f   Gorenflo, Matthias ^b   Habighorst, Matthias ^a,c   Vogel, Martin ^a   Lange, Peter E ^d   Hocher, Berthold ^c,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

^d DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Congenital heart disease; Endothelin A receptor; Endothelin 1; Pulmonary hypertension

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; VASOCONSTRICTOR AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; LUNG ARTERY; LUNG BIOPSY; LUNG CIRCULATION; LUNG PARENCHYMA; LUNG RESISTANCE; MALE; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR DENSITY;

EID: 0032891535     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.1999.069     Document Type: Article

References (20)

1. Hall SM, Haworth SG. Onset and evolution of pulmonary vascular disease in children: abnormal postnatal remodeling studied in lung biopsies. J Pathol 1992; 166:183-94.
2. Haworth SG. Pulmonary vascular disease in different types of congenital heart disease. Implications for interpretation of lung biopsy findings in early childhood. Br Heart J 1984; 52:557-71.
3. Heath D, Edwards JE. The pathology of pulmonary vascular disease. A description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18:533-47.
4. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978; 58:1107-22.
5. Wagenvoort CA. Grading of pulmonary vascular lesions - a reappraisal. Histopathology 1981; 5:595-8.
6. Levin ER. Mechanisms of disease: endothelins. N Engl J Med 1995; 333:356-64.
7. Hocher B, Thöne-Reineke C, Bauer C, Raschack M, Neumayer HH. The paracrine endothelin system: pathophysiology and implications in clinical medicine. Eur J Clin Chem Clin Biochem 1997; 35:175-89.
8. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, ShennibH, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N EnglJ Med 1993; 328: 1732-9.
9. Janakidevi K, Fisher MA, Del Vecchio PJ, Tiruppathi C, Figge J, Malik AB. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol 1992; 263:C1295-C301.
10. Freed MD. Invasive diagnostic and therapeutic techniques. Part 1. Cardiac catheterization. In: Adams FH, Emmanouilides GC, Riemenschneider TA, editors. Moss' heart disease in infants, children, and adolescents. 4th ed. Baltimore: Williams & Wilkins, 1989:130-47.
11. Hocher B, Rohmeiss P, Zart R, Diekmann F, Braun C, Koppenhagen K, et al. Distribution of endothelin receptor subtypes in the rat kidney; renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan. Eur J Clin Chem Clin Biochem 1995; 33:463-72.
12. Stewart DJ. Endothelin in cardiopulmonary disease: factor paracrine vs. neurohumoral. Eur Heart J 1993; 14 (Suppl 1):48-54.
13. Li H, Elton S, Chen YF, Oparil S. Increased endothelin receptor gene expression in hypoxic rat lung. Am J Physiol 1994; 266:L553-L6.
14. Clozel M, Löffler B-M, Breu V, Hilfiger L, Maire J-P, Butscha B. Downregulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 1993; 265:C188-C92.
15. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circulation Res 1993; 73:887-97.
16. A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am J Physiol 1994; 266:H1327-H31.
17. A-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol 1995; 269:L690-L7.
18. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM. Prolonged endothelin-A receptor bolockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 1997; 99:1179-86.
19. Takahashi T, Kanda T, Inoue M, Sumino H, Kobayashi I, Iwamoto A, et al. Endothelin converting enzyme protects development of right ventricular overload and medial thickening of pulmonary arteries in rats with monocrotaline-induced pulmonary hypertension. Life Sci 1998; 63:PL 137-PL 43.
20. Cacoub P, Dorent R, Nataf P, Carayon A, Riquet M, Noe E, et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997; 33:196-200.